Canada· CA-DIN-02486598
GAMASTAN
A humane immunglobuline, unspezifisch, extravaskulär product containing immunoglobulin (human), registered in Canada by GRIFOLS THERAPEUTICS LLC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Humane immunglobuline, unspezifisch, extravaskulär is registered in 11 of 19 countries.
Countries holding a registration under ATC J06BA01 (humane immunglobuline, unspezifisch, extravaskulär), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Humane immunglobuline, unspezifisch, extravaskulär · ATC J06BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- IMMUNOGLOBULIN (HUMAN)
- Manufacturer
- GRIFOLS THERAPEUTICS LLC
- Country
- Canada (CA)
- ATC code
- J06BA01
- ATC class
- Humane Immunglobuline, unspezifisch, extravaskulär
- Defined daily dose
- 1.4 g, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
48 interactions on record for humane immunglobuline, unspezifisch, extravaskulär.
Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Humane immunglobuline, unspezifisch, extravaskulär · interactions on record
48 records
- 44 severe
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J06BA01
Humane immunglobuline, unspezifisch, extravaskulär, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1e7c6bd-ad4a-4fd9-a176-fbc8a4fa3dcf GET /v1/drugs/e1e7c6bd-ad4a-4fd9-a176-fbc8a4fa3dcf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02486598",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J06BA01",
"schedule": [
"Schedule D"
],
"drug_code": "97678",
"strengths": [
"18 %"
],
"ahfs_class": null,
"substances": [
"IMMUNOGLOBULIN (HUMAN)"
],
"product_categorization": null
}See everything about humane immunglobuline, unspezifisch, extravaskulär.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.